Resistance of t(17;19)‐acute lymphoblastic leukemia cell lines to multiagents in induction therapyAtsushi Watanabe, Kanji Sugita, Hiroko Fukushima et al.|Cancer Medicine|2019Cited by 22
Induction of CD33 Expression in B-Precursor ALL by E2A-HLF Fusion Transcription Factor Derived from t(17;19).Koshi Akahane, Shinpei Nakazawa, Takeshi Inukai et al.|Blood|2005Cited by 0
Induction of Death Receptors for TRAIL, a Cytotoxic Factor for GVL Effect, by Oncogenic Fusion E2A-HLF Derived from t(17;19)-Positive Acute Lymphoblastic Leukemia.Xiaochun Zhang, Kanji Sugita, Takeshi Inukai et al.|Blood|2007Cited by 0